Radnor Capital Management LLC Invests $497,000 in Healthequity Inc (NASDAQ:HQY)

Radnor Capital Management LLC purchased a new position in shares of Healthequity Inc (NASDAQ:HQY) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 8,700 shares of the company’s stock, valued at approximately $497,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. US Bancorp DE raised its stake in Healthequity by 36.2% in the first quarter. US Bancorp DE now owns 11,670 shares of the company’s stock valued at $862,000 after buying an additional 3,101 shares in the last quarter. Swiss National Bank boosted its position in Healthequity by 3.4% in the 1st quarter. Swiss National Bank now owns 102,100 shares of the company’s stock valued at $7,553,000 after buying an additional 3,400 shares during the last quarter. Sawtooth Solutions LLC purchased a new position in Healthequity in the 1st quarter valued at about $325,000. Rockefeller Capital Management L.P. boosted its position in Healthequity by 21.6% in the 1st quarter. Rockefeller Capital Management L.P. now owns 2,904 shares of the company’s stock valued at $215,000 after buying an additional 515 shares during the last quarter. Finally, AlphaCrest Capital Management LLC purchased a new position in Healthequity in the 1st quarter valued at about $296,000. Institutional investors and hedge funds own 83.65% of the company’s stock.

A number of equities analysts have weighed in on the stock. Deutsche Bank assumed coverage on shares of Healthequity in a research report on Thursday, September 12th. They issued a “buy” rating and a $74.00 price objective for the company. BidaskClub lowered shares of Healthequity from a “hold” rating to a “sell” rating in a research note on Friday. TheStreet lowered shares of Healthequity from a “b” rating to a “c+” rating in a research note on Tuesday, September 3rd. Oppenheimer lowered their price objective on shares of Healthequity from $98.00 to $76.00 and set an “outperform” rating on the stock in a research note on Wednesday, September 4th. Finally, ValuEngine lowered shares of Healthequity from a “buy” rating to a “hold” rating in a research note on Tuesday, August 6th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $77.29.

In other news, CFO Darcy G. Mott sold 4,000 shares of the company’s stock in a transaction that occurred on Friday, September 20th. The shares were sold at an average price of $61.61, for a total value of $246,440.00. Following the completion of the transaction, the chief financial officer now owns 46,000 shares in the company, valued at $2,834,060. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Jon Kessler purchased 10,000 shares of Healthequity stock in a transaction dated Friday, July 12th. The stock was bought at an average price of $61.00 per share, with a total value of $610,000.00. Following the acquisition, the chief executive officer now directly owns 442,410 shares of the company’s stock, valued at $26,987,010. The disclosure for this purchase can be found here. In the last 90 days, insiders have sold 37,899 shares of company stock valued at $2,711,131. Corporate insiders own 3.70% of the company’s stock.

Shares of NASDAQ HQY traded up $0.34 during trading on Monday, reaching $54.88. The company had a trading volume of 5,730 shares, compared to its average volume of 933,530. Healthequity Inc has a 52 week low of $50.29 and a 52 week high of $101.58. The stock has a market cap of $3.85 billion, a PE ratio of 57.74, a PEG ratio of 3.13 and a beta of 1.52. The company has a debt-to-equity ratio of 0.04, a quick ratio of 22.98 and a current ratio of 22.98. The business’s 50 day moving average price is $58.81 and its 200-day moving average price is $68.29.

Healthequity (NASDAQ:HQY) last announced its earnings results on Tuesday, September 3rd. The company reported $0.36 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.26 by $0.10. The company had revenue of $86.60 million during the quarter, compared to the consensus estimate of $85.33 million. Healthequity had a net margin of 28.13% and a return on equity of 11.77%. The company’s revenue was up 21.8% on a year-over-year basis. During the same period in the previous year, the firm posted $0.36 earnings per share. Equities analysts anticipate that Healthequity Inc will post 0.87 earnings per share for the current year.

Healthequity Company Profile

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Featured Story: How to track put option volume

Institutional Ownership by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.